These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 37064609)

  • 41. Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.
    Cuadrado I; Saura M; Castejón B; Martin AM; Herruzo I; Balatsos N; Zamorano JL; Zaragoza C
    Expert Rev Mol Med; 2016 Apr; 18():e6. PubMed ID: 27056676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
    Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
    Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis.
    Zia A; Wu Y; Nguyen T; Wang X; Peter K; Ta HT
    Cardiovasc Res; 2020 Nov; 116(13):2055-2068. PubMed ID: 32077918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.
    MacAskill MG; Newby DE; Tavares AAS
    Cardiovasc Res; 2019 Dec; 115(14):1952-1962. PubMed ID: 31233100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorescent probes for imaging: a focus on atherosclerosis.
    Jia J; Li L; Wu Z; Li S
    Nanoscale; 2024 Jun; 16(25):11849-11862. PubMed ID: 38836376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression.
    Millon A; Canet-Soulas E; Boussel L; Fayad Z; Douek P
    Vascular; 2014 Jun; 22(3):221-37. PubMed ID: 24907292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
    Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
    Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PET imaging of atherosclerosis.
    Tarkin JM; Joshi FR; Rajani NK; Rudd JH
    Future Cardiol; 2015; 11(1):115-31. PubMed ID: 25606707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography.
    Hyafil F; Feldman L; Le Guludec D; Fayad ZA
    Mt Sinai J Med; 2012; 79(6):689-704. PubMed ID: 23239208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque.
    Anwaier G; Chen C; Cao Y; Qi R
    Int J Nanomedicine; 2017; 12():7681-7693. PubMed ID: 29089763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques.
    Lee SJ; Paeng JC
    Korean J Radiol; 2015; 16(5):955-66. PubMed ID: 26357491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of vulnerable atherosclerosis plaques with a dual-modal single-photon-emission computed tomography/magnetic resonance imaging probe targeting apoptotic macrophages.
    Cheng D; Li X; Zhang C; Tan H; Wang C; Pang L; Shi H
    ACS Appl Mater Interfaces; 2015 Feb; 7(4):2847-55. PubMed ID: 25569777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current and Emerging Preclinical Approaches for Imaging-Based Characterization of Atherosclerosis.
    Vigne J; Thackeray J; Essers J; Makowski M; Varasteh Z; Curaj A; Karlas A; Canet-Soulas E; Mulder W; Kiessling F; Schäfers M; Botnar R; Wildgruber M; Hyafil F;
    Mol Imaging Biol; 2018 Dec; 20(6):869-887. PubMed ID: 30250990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 56. Hyaluronic Acid-Guided Cerasome Nano-Agents for Simultaneous Imaging and Treatment of Advanced Atherosclerosis.
    Ma Q; Wu S; Yang L; Wei Y; He C; Wang W; Zhao Y; Wang Z; Yang S; Shi D; Liu Y; Zhou Z; Sun J; Zhou Y
    Adv Sci (Weinh); 2023 Feb; 10(5):e2202416. PubMed ID: 36529695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.
    Boswijk E; Bauwens M; Mottaghy FM; Wildberger JE; Bucerius J
    Methods; 2017 Nov; 130():90-104. PubMed ID: 28602809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Theranostics of Atherosclerosis by Dual-Responsive Nanoplatform via Photoacoustic Imaging and Three-In-One Integrated Lipid Management.
    Ma B; Xiao Y; Lv Q; Li G; Wang Y; Fu G
    Adv Mater; 2023 Feb; 35(5):e2206129. PubMed ID: 36394179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.